Table 3.
Patient’s characteristics.
| Authors | Age (Years) | BCVA (LogMAR) | SLE Duration (Years) | SLEDAI | SLICC/ACR SDI |
|---|---|---|---|---|---|
| Conigliaro et al. [20] | 49.6 ± 13.6 | 0.0 ± 0.1 | 15.1 ± 7.7 | 4.3 ± 4.4 | 1.9 ± 1.5 |
| Forte et al. [23] | 38.87 ± 8.6 | 0.01 ± 0.03 | 10.25 ± 3.28 (6–16) | Not calculated | Not calculated |
| Bao et al. [24] | 34.9 ± 11.8 | −0.01 ± 0.04 | 3.8± 3.0 | 7.7 ± 8.1 | Not calculated |
| Işık et al. [21] | 42.6 ± 9.2 | 0.02 ± 0.04 | 10.6 ± 4.4 | Not calculated | Not calculated |
| Pichi et al. [25] | 42.3 ± 13.4 | 1 20/25 | 11.3 ± 6.8 | 0 in 6 patients 1–8 in 8 patient 1 >8 in one patient (no clearly stated data in paper) |
Not calculated |
| Mihailovic et al. [22] | 40.1 ± 11.5 | Not evaluated | Not evaluated | Not calculated | Not calculated |
| Arfeen et al. [26] | 29.20 ± 7.90 | 2 0.85 ± 0.08 | Unknown | No–8 patients Mild–2 patients Moderate–10 patients Severe–0 patients |
0–10 patients 2–6 patients 3–2 patients 6–2 patients |
1 Authors evaluated only mean BCVA. 2 BCVA—Snellen decimal. Continuous variables were shown using mean and SD. BCVA–best corrected visual acuity. SLEDAI–Systemic Lupus Erythematosus Disease Activity Index. SLICC/ACR SDI–Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index.